Lorenzo Fornaro
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 171 publications
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2026
Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.
Journal: ESMO gastrointestinal oncology
Published: May 22, 2026
Reply to: "Establish a streamlined molecular profiling workflow for the clinical management of advanced cholangiocarcinoma".
Journal: Journal of hepatology
Published: May 05, 2026
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real-World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab.
Journal: International journal of cancer
Published: March 23, 2026
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting.
Journal: International journal of cancer
Published: February 15, 2026
The role of the molecular tumor board: learnings from the ROME trial.
Journal: NPJ precision oncology
Published: November 18, 2025
Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort.
Journal: ESMO open
Published: October 31, 2025
Editorial: Innovative approaches to cholangiocarcinoma: diagnosis, treatment, and multidisciplinary care.
Journal: Frontiers in oncology
Published: October 01, 2025
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.
Journal: Targeted oncology
Published: September 18, 2025
Letter Re: Reflections on the MAGIC-D Prognostic Model in Advanced Biliary Tract Cancer.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 28, 2025
Last Updated: 09/26/2026